U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Structurally Diverse
Created
by admin
on Fri Jun 25 22:20:29 UTC 2021
Edited
by admin
on Fri Jun 25 22:20:29 UTC 2021
Source Materials Class ORGANISM
Source Materials Type CHROMALVEOLATE
Organism Family PLASMODIIDAE
Organism Genus PLASMODIUM
Organism Species FALCIPARUM
Author WELCH
Part WHOLE
Record UNII
536WV61NML
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PLASMODIUM FALCIPARUM
Common Name English
Code System Code Type Description
FDA UNII
536WV61NML
Created by admin on Fri Jun 25 22:20:29 UTC 2021 , Edited by admin on Fri Jun 25 22:20:29 UTC 2021
PRIMARY
NCBI TAXONOMY
5833
Created by admin on Fri Jun 25 22:20:29 UTC 2021 , Edited by admin on Fri Jun 25 22:20:29 UTC 2021
PRIMARY
Related Record Type Details
VACCINE ANTIGEN->TARGET ORGANISM
INHIBITOR->TARGET ORGANISM
INHIBITOR->TARGET ORGANISM
INHIBITOR->TARGET ORGANISM
INHIBITOR OF CD
INHIBITOR->TARGET ORGANISM
INHIBITOR->TARGET ORGANISM
DSM265 displayed maximum antimalarial effects at 3 × EC50 and above, requiring a 24- to 48-hour lag phase before parasite killing. At 1 × EC50, DSM265 parasite killing was further delayed (96-hour lag phase).
EC50
INHIBITOR->TARGET ORGANISM
INHIBITOR->TARGET ORGANISM
Whole-cell blood stage activity of UCT943 against a panel of resistant P. falciparum strains to determine potential for cross-resistance compared with MMV048, chloroquine (CQ) and artesunate (AS)
IC50
INHIBITOR->TARGET ORGANISM
Chloroquine resistant strains
IC50
INHIBITOR->TARGET ORGANISM
INHIBITOR->TARGET ORGANISM
IC50
INHIBITOR->TARGET ORGANISM
INHIBITOR->TARGET ORGANISM
VACCINE ANTIGEN->TARGET ORGANISM
INHIBITOR->TARGET ORGANISM
Whole-cell blood stage activity of UCT943 against a panel of resistant P. falciparum strains to determine potential for cross-resistance compared with MMV048, chloroquine (CQ) and artesunate (AS)
INHIBITOR->TARGET ORGANISM
Whole-cell blood stage activity of UCT943 against a panel of resistant P. falciparum strains to determine potential for cross-resistance compared with MMV048, chloroquine (CQ) and artesunate (AS)
IC50